JPM
60
-3
SYF
79
-6
F
39
-8
AMZN
51
-6
HAS
35
-2
MA
55
-9
TXN
45
-5
OKE
70
3
SPG
53
-3
NTAP
54
-2
DOV
59
-6
CRM
57
-2
ADM
27
2
GLW
50
-2
CME
56
-2
MDLZ
36
-2
NRG
69
7
OI
24
-4
VMC
69
-3
MKC
53
2
JPM
60
-3
SYF
79
-6
F
39
-8
AMZN
51
-6
HAS
35
-2
MA
55
-9
TXN
45
-5
OKE
70
3
SPG
53
-3
NTAP
54
-2
DOV
59
-6
CRM
57
-2
ADM
27
2
GLW
50
-2
CME
56
-2
MDLZ
36
-2
NRG
69
7
OI
24
-4
VMC
69
-3
MKC
53
2
Financhill
Back

Madrigal Pharmaceuticals 10K Form

Buy
71

MDGL
Madrigal Pharmaceuticals

Last Price:
259.70
Seasonality Move:
31.67%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MDGL News And Ratings

See the #1 stock for the next 7 days that we like better than MDGL

MDGL Financial Statistics

Sales & Book Value

Annual Sales: $150K
Cash Flow: $-140.08M
Price / Cash Flow: 0
Annual Sales: $39.50
Price / Book: 6.57

Profitability

EPS (TTM): -25.54000
Net Income (TTM): $-510.45M
Gross Margin: $0
Return on Equity: -113.99%
Return on Assets: -75.89%

Madrigal Pharmaceuticals Earnings Forecast

Key Madrigal Pharmaceuticals Financial Ratios

  • The Selling, General & Administrative Expenses for MDGL have been equal to 7,786.67% of Gross Profit Margin.
  • The Interest Expense is -3.40% of Operating Income.
  • Per Share Earnings over the last 23 years have been positive in 8 years.

Madrigal Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MDGL
CUSIP: 558868
Website: madrigalpharma.com

Debt

Debt-to-Equity Ratio: 0.14
Current Ratio: 8.72
Quick Ratio: 8.51

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MDGL Technical Analysis vs Fundamental Analysis

Buy
71
Madrigal Pharmaceuticals (MDGL) is a Buy

Is Madrigal Pharmaceuticals a Buy or a Sell?